Keyword: Johnson & Johnson
News
28.01.2016
- Three major drugs companies have joined forces with three leading UK universities to translate ground-breaking academic science into new medicines for a broad range of diseases...
News
27.01.2016
- Geneva, Switzerland-based GAVI (Global Alliance for Vaccines and Immunization), a public-private partnership, and Merck Sharp & Dohme (MSD), known in the US as Merck & Co, have...
News
20.01.2016
- US healthcare giant Johnson & Johnson has announced it will eliminate about 3,000 jobs in its medical devices division, or about 4-6% of the unit’s global workforce. The move is...
News
12.01.2016
- Globally, mergers and acquisitions at a value of USD 372 billion were recorded in the chemical and pharmaceutical sector in 2015. This amounts to an increase of 74% compared with...
News
16.10.2015
- Canada’s enGne, a gene therapy company focused on development of therapeutics using its proprietary “Gene Pill”, and Janssen Biotech, one of the Janssen Pharmaceutical Companies of...
News
14.10.2015
- US drugmaker Johnson & Johnson (J&J), the country’s largest healthcare company, in particular in the consumer segment, has launched a $10 billion debt-financed share buyback...
Markets & Companies
07.10.2015
- After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...
News
22.09.2015
- Bavarian Nordic, a Danish biotechnology company specializing in research, development and manufacture of active cancer immunotherapies and vaccines for infectious diseases, has...
